Beyond Conventional Medicine – a Look at Blueberry, a Cancer-Fighting Superfruit

Kristoffer T Davidson, Ziwen Zhu, Dean Balabanov, Lei Zhao, Mark R Wakefield, Qian Bai, Yujiang Fang
Pathol Oncol Res . 2018 Oct;24(4):733-738.

Nearly 40% of men and women will be diagnosed with cancer during their lifetime. Thus, there is a rapidly growing need for novel therapies to combat this deadly disease. One such method is the consumption of blueberries. Long coveted for their powerful antioxidant properties, more recent studies have demonstrated that blueberries also exhibit inherent abilities to prevent carcinogenesis, inhibit the proliferation of neoplastic cells, and reduce the risks of recurrence in patients in remission. This review will focus on the specific activities of blueberry derivatives in cancer cells across many different forms of cancer. Ultimately, such research could be helpful in the development of new strategies to treat cancer.

Latest Cancer


Postdiagnostic Fruit and Vegetable Consumption and Breast Cancer Survival: Prospective Analyses in the Nurses’ Health Studies

Maryam S Farvid, Michelle D Holmes, Wendy Y Chen, Bernard A Rosner, Rulla M Tamimi, Walter C Willett, A Heather Eliassen
Cancer Res . 2020 Nov 15;80(22):5134-5143.
Read More

Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin

H Lamdan, R S Garcia-Lazaro, N Lorenzo, L G Caligiuri, D F Alonso, H G Farina
Exp Oncol . 2020 Jun;42(2):101-108.
Read More

Blueberry and malvidin inhibit cell cycle progression and induce mitochondrial-mediated apoptosis by abrogating the JAK/STAT-3 signalling pathway

Abdul Basit Baba, Ramesh Nivetha, Indranil Chattopadhyay, Siddavaram Nagini
Food Chem Toxicol . 2017 Nov;109(Pt 1):534-543.
Read More